ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2026
[Expert consensus on overall standardized management of gadoxetate disodium-enhanced MRI examinations (version 2026)].
Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Gadoxetate disodium (Gd-EOB-DTPA), as a hepatocyte-specific MRI contrast agent, plays a key role in the early-stage diagnosis, differential diagnosis, and treatment evaluation of liver diseases. Gd-EOB-DTPA-enhanced MRI has been recommended as a first-line imaging diagnostic method for the diagnosis of liver lesions by clinical guidelines in many countries and regions. However, there is currently a lack of standardized management consensus to guide the clinical practice of Gd-EOB-DTPA-enhanced MRI examinations. Therefore, there is an urgent need to establish a scientifically based, full-process management protocol to improve image quality and professional standards and ensure the effectiveness of examinations. The "Expert Consensus on Standardized Management of Gadoxetate Disodium-Enhanced MRI Examinations (version 2026)" integrates the latest evidence-based data and clinical experience to standardize the entire process-from contrast agent storage management, pre-examination assessment and preparation, and operational coordination during the examination to post-examination observation guidance. In addition, it aims to enhance the professional competence and emergency response level of radiology medical personnel, thereby improving patient compliance, diminishing the incidence rate of adverse events, and providing a scientific and reliable clinical practice basis for the standardized implementation and technical promotion of Gd-EOB-DTPA-enhanced MRI examination in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.